RPGR相关视网膜表型中中心视网膜敏感度下降的自然史
回顾性队列研究纳入50例RPGR突变患者(36例视杆-视锥型、14例视锥-视杆型营养不良),共357次微视野检查,评估中心视网膜敏感度随时间的下降速率。视锥-视杆型患者MS16年下降10.8% vs 视杆-视锥型5.1%(P=0.02),MS4年下降14.9% vs 4.1%(P<0.001),视锥-视杆型中心视力丧失风险约为视杆-视锥型的7.2-8.2倍。
要点
- 视锥-视杆型RPGR患者MS16年下降10.8%,视杆-视锥型为5.1%(P=0.02)
- 视锥-视杆型MS4年下降14.9%,视杆-视锥型为4.1%(P<0.001)
- 视锥-视杆型中心视力丧失瞬时风险为视杆-视锥型的8.2倍(MS16)和7.2倍(MS4)
核心结论
- RPGR相关视网膜病变中视锥-视杆型与视杆-视锥型的功能下降速率显著不同,视锥-视杆型患者早期中心视力丧失风险明显更高。
- 微视野检查可作为敏感的结果指标,所获生存数据可用于临床试验设计、患者咨询和治疗优先级排序。
- 作者认为以视锥细胞为主的表型患者可能从更早的干预中获益。
研究设计与样本
- 回顾性队列研究,纳入50例经基因确诊的RPGR突变患者(36例视杆-视锥型、14例视锥-视杆型营养不良),共357次微视野评估。
- 采用标准68点MAIA微视野网格,暗适应20分钟后在不散瞳条件下检查,提取中心4个位点(MS4)和16个位点(MS16)的平均敏感度进行分析。
- 纵向下降速率采用广义线性混合模型建模,生存分析采用Cox比例风险模型,纳入随机截距和稳健聚类以处理重复测量和个体内相关性。
主要发现
- MS16年下降速率视锥-视杆型为10.8%(95%CI:6.6,14.8),视杆-视锥型为5.1%(95%CI:2.9,7.1),P=0.02。
- MS4年下降速率视锥-视杆型为14.9%(95%CI:10.2,19.4),视杆-视锥型为4.1%(95%CI:1.2,6.8),P<0.001。
- MS16敏感度完全丧失的中位生存年龄视锥-视杆型为25.1岁、视杆-视锥型为33.1岁(P=0.01);MS4分别为27.2岁和33.3岁(P=0.02)。
- 风险比显示视锥-视杆型相比视杆-视锥型中心视力丧失的瞬时风险增加8.2倍(MS16)和7.2倍(MS4)。
临床怎么用
- 作者认为微视野检查可作为敏感的结果指标用于临床试验设计。
- 作者认为所获生存数据可用于患者咨询和治疗优先级排序。
- 作者认为以视锥细胞为主的表型患者可能从更早的干预中获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the natural history of central retinal sensitivity decline in RPGR-associated retinopathy and to evaluate and quantify phenotypic differences in disease progression using microperimetry-derived metrics. DESIGN: A retrospective cohort study. SUBJECTS: 50 patients with genetically confirmed RPGR mutations (36 rod-cone, 14 cone-rod dystrophy [CORD], contributing 357 microperimetry assessments) were recruited. METHODS: Central retinal function was assessed using the standard 68-point MAIA microperimeter grid pattern after 20 minutes of dark adaptation and without dilation. Mean sensitivity across the central 4 (MS4) and 16 (MS16) loci were extracted and analyzed post hoc. Longitudinal decline rates were modeled using generalized linear mixed models, and survival analyses were conducted using Cox proportional hazards models with random intercepts and robust clustering to account for repeated measures and intra-subject correlation. MAIN OUTCOME MEASURES: The rate of retinal sensitivity decline was measured. RESULTS: CORD patients exhibited significantly faster rates of central retinal sensitivity decline. The annual MS16 decline rate was 10.8% (95% CI: 6.6, 14.8) in CORD vs 5.1% (95% CI: 2.9, 7.1) in rod-cone patients (P = .02). MS4 declined by 14.9% (95% CI: 10.2, 19.4) annually in CORD compared to 4.1% (95% CI: 1.2, 6.8) in rod-cone (P < .001). The median survival age to total loss of sensitivity for MS16 was 25.1 years in CORD and 33.1 years in rod-cone (P = .01), and for MS4, 27.2 years and 33.3 years, respectively (P = .02). Hazard ratios demonstrated an 8.2-fold (MS16) and 7.2-fold (MS4) increased instantaneous risk of central vision loss in CORD compared with rod-cone patients. CONCLUSIONS: This study reveals significantly different rates of functional decline between RPGR phenotypes, with CORD patients at markedly higher risk of early central vision loss. These findings support the use of microperimetry as a sensitive outcome measure and provide critical survival data for clinical trial design, patient counseling, and therapeutic prioritization. Patients with cone-dominated phenotypes may benefit from earlier intervention.
引用
- Josan AS, Taylor LJ, Raji S, et al. Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes. Am J Ophthalmol. 2025. PMID: 41237986. doi:10.1016/j.ajo.2025.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。